市场快照

Study Period: | 2018 - 2026 |
Base Year: | 2021 |
CAGR: | 12.5 % |
![]() |
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
广泛作为驱动因素的主要因素包括中国呼吸系统疾病的高发病率、经济和人口趋势的持续、技术进步以及家庭护理环境中应用的增加。在中国,慢性呼吸系统疾病是第二大死因。据估计,超过 50% 的中国男性吸烟,而该国女性的吸烟率较低。根据杜兰大学 2018 年发表的一项新研究,慢性阻塞性肺病 (COPD) 在中国很普遍,近 1 亿人患有慢性肺病。该疾病的最大可预防风险因素是吸烟和空气污染以及因此,中国的公共卫生优先事项是减少与慢性阻塞性肺病相关的疾病和死亡。
报告范围
根据报告的范围,呼吸装置是指以机械方式向呼吸功能受损的患者供应呼吸气体。呼吸气体通常富含氧气,并通过设备产生的正压输送到肺部。呼吸装置包括呼吸诊断装置、治疗装置和用于进行长期人工呼吸的呼吸装置。
By Type | ||||||||||
| ||||||||||
| ||||||||||
|
主要市场趋势
在预测期内,肺活量计有望成为诊断和监测设备的主导部分
肺活量计有助于诊断呼吸系统疾病,例如哮喘、肺气肿、支气管炎和慢性阻塞性肺病。此外,它们还可用于评估呼吸急促、手术前的肺功能以及药物的效果。
肺量计领域受到近期技术进步的推动,在肺量计领域,包括小型便携式肺量计的开发以及评估的准确性、可接受性和可重复性的提高,并立即反馈给技术人员。因此,肺活量计的应用使患者更容易使用这种诊断设备,并且在医院和家庭护理中也越来越多地采用。此外,中国有几家从事呼吸设备业务的中小型公司,其中美国、德国和日本的外国产品或品牌具有重要影响力。

To understand key trends, Download Sample Report
竞争格局
许多公司都专注于中国各地的呼吸产品。这些公司正在实施某些战略举措,例如合并、新产品发布、收购和合作伙伴关系,以帮助他们加强市场地位。例如,2017 年,Drägerwerk AG & CO. KGAA 推出了 Oxylog VE300,这是一种新开发的紧急和转运呼吸机,特别适合在医院环境之外使用。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, and Asthma
-
4.2.2 Technological Advancements and Increasing Applications in Homecare Setting
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Devices
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Type
-
5.1.1 By Diagnostic and Monitoring Devices
-
5.1.1.1 Spirometers
-
5.1.1.2 Sleep Test Devices
-
5.1.1.3 Peak Flow Meters
-
5.1.1.4 Pulse Oximeters
-
5.1.1.5 Capnographs
-
5.1.1.6 Other Diagnostic and Monitoring Devices
-
-
5.1.2 By Therapeutic Devices
-
5.1.2.1 CPAP Devices
-
5.1.2.2 BiPAP Devices
-
5.1.2.3 Humidifiers
-
5.1.2.4 Nebulizers
-
5.1.2.5 Oxygen Concentrators
-
5.1.2.6 Ventilators
-
5.1.2.7 Inhalers
-
5.1.2.8 Other Therapeutic Devices
-
-
5.1.3 By Disposables
-
5.1.3.1 Masks
-
5.1.3.2 Breathing Circuits
-
5.1.3.3 Other Disposables
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 DeVilbiss Healthcare LLC
-
6.1.2 Dragerwerk AG
-
6.1.3 Fisher & Paykel Healthcare Ltd
-
6.1.4 GE Healthcare
-
6.1.5 GlaxoSmithKline PLC
-
6.1.6 Koninklijke Philips NV
-
6.1.7 Medtronic PLC
-
6.1.8 ResMed Inc.
-
6.1.9 Vincent Medical
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The China Respiratory Devices Market market is studied from 2018 - 2026.
What is the growth rate of China Respiratory Devices Market?
The China Respiratory Devices Market is growing at a CAGR of 12.5% over the next 5 years.
Who are the key players in China Respiratory Devices Market?
DeVilbiss Healthcare LLC, Dragerwerk AG, Fisher & Paykel Healthcare Ltd, GE Healthcare, GlaxoSmithKline PLC are the major companies operating in China Respiratory Devices Market.